MetaCap

eXoZymes Statistics

NASDAQ: EXOZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

5.54-0.18 (-3.15%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

eXoZymes by the numbers

eXoZymes has a market capitalization of $51.5 million based on 9.30M shares outstanding. With trailing EPS of $-1.19, eXoZymes is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.9% below its 50-day average and 33.5% below its 200-day average.

Average daily trading volume is 6.80K shares, or about $37,661 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EXOZ valuation vs. peer median

EXOZ compared with the median of 8 peer companies
MetricEXOZPeer medianDifference
Market cap$51.55M$53.22M-3%
Avg. volume6.80K30.32K-78%

Peer median across 8 companies: INMB, IMA, BKHA, LONA, TIL, BSEM, INKT, ELOX.

Valuation

Price and trading

Previous close
5.72
Open
5.54
Day range
5.52 – 5.71
52-week range
4.35 – 18.40
52-week change
-58.96%
Beta
—
Volume
7.44K

Dividends and events

Annual dividend
None
Next earnings date
May 12, 2025

Additional statistics

Market Cap
51.55M
Eps
-1.19
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
18.40
Week52 Low
4.35
Avg Volume
6,798.00
Shares Outstanding
9.30M
Ma50
6.08
Ma200
8.33
Earnings Date
May 12, 2025
Pct From52w High
-69.89%
Pct From52w Low
27.36%

Related